IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Allogene Therapeutics, Inc.

Q1 2019 vs Q2 2019

Comparing institutional holders between quarters

Quarters

Q2 2019Q1 2019
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Private Capital Advisors, Inc.
INCREASED
Shares10,000 from 9,000
Change+1,000 (+11%)
Value$268 (+$8)
Filed 2019-07-18
Status
Private Capital Advisors, Inc.
INCREASED10,0009,000+1,000+11%$260$268+$82019-07-18
Showing 1 of 1 institutions